Provides Update on FDA-EUA Application Process
- Toronto, Ontario--(Newsfile Corp. - September 14, 2021) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announced today its successful up-listing from the OTC Pink Sheets to the OTCQB Venture Market (the "OTCQB").
- Therma Bright will commence trading on the OTCQB with the market open on September 14, 2021, under the symbol "TBRIF".
- "We're excited to be up-listed to the OTCQB, which is an important milestone for Therma Bright," shared Rob Fia, CEO of Therma Bright.
- Therma Bright Inc. trades on the TSXV (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX).